Literature DB >> 13801696

The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.

L BLUM, L PILLEMER, I H LEPOW.   

Abstract

Keywords:  PROPERDIN/chemistry

Mesh:

Substances:

Year:  1959        PMID: 13801696

Source DB:  PubMed          Journal:  Z Immun exp ther        ISSN: 0372-9052


× No keyword cloud information.
  14 in total

1.  The Bf locus in the HLA region of chromosome 6: linkage and association studies.

Authors:  B Olaisen; P Teisberg; T Gedde-Dahl; E Thorsby
Journal:  Humangenetik       Date:  1975-12-23

2.  The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

Authors:  P A Nicol; P J Lachmann
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

Review 3.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

4.  Linkage group HL-A-MLC-BF (properdin factor B). The site of the Bf locus at the immunogenetic linkage group on chromosome 6.

Authors:  C Rittner; H Grosse-Wilde; B Netzel; S Scholz; H Lorenz; E D Albert
Journal:  Humangenetik       Date:  1975

5.  Inactivator of the third component of complement as an inhibitor in the properdin pathway.

Authors:  C A Alper; F S Rosen; P J Lachmann
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

6.  Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

7.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

8.  Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.

Authors:  R H McLean; A F Michael
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

Review 9.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

10.  Properdin: initiation of alternative complement pathway.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.